Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomatrica
San Diego, California, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Biomatrica commercializes proprietary dry and liquid chemical reagent platforms for ambient temperature stabilization of DNA, RNA, cells, and proteins, enabling broader access and higher quality results in diagnostics, biobanking, research, and forensics[2][6][4][1]. The technology is widely used and has been licensed and distributed by major biotech players.
- Therapeutic areas
- Other
- Modalities
- DeviceChemical reagentBiologic stabilization reagent
- Industry
- Chemicals & Materials
02
Partnerships
QiagenSigma-AldrichAmerican Type Culture Collection (ATCC)US Army Medical Research Institute for Infectious Diseases (USAMRIID)National Cancer Institute (NCI)In-Q-TelSAIC-FrederickBioStorage Technologies
Beyond the preview
Go deeper on Biomatrica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biomatrica.